Human Ebola virus infection results in substantial immune activation.
McElroy, Anita K; Akondy, Rama S; Davis, Carl W; Ellebedy, Ali H; Mehta, Aneesh K; Kraft, Colleen S; Lyon, G Marshall; Ribner, Bruce S; Varkey, Jay; Sidney, John; Sette, Alessandro; Campbell, Shelley; Ströher, Ute; Damon, Inger; Nichol, Stuart T; Spiropoulou, Christina F; Ahmed, Rafi.
Proc Natl Acad Sci U S A
; 112(15): 4719-24, 2015 Apr 14.
Artigo em Inglês | MEDLINE | ID: mdl-25775592
Camouflage and misdirection: the full-on assault of ebola virus disease.
Human Adaptation of Ebola Virus during the West African Outbreak.
Protein Interaction Mapping Identifies RBBP6 as a Negative Regulator of Ebola Virus Replication.
Unique human immune signature of Ebola virus disease in Guinea.
Ebola Virus Glycoprotein with Increased Infectivity Dominated the 2013-2016 Epidemic.
Enhancement of Ebola virus infection by seminal amyloid fibrils.
Structural Insights into the Niemann-Pick C1 (NPC1)-Mediated Cholesterol Transfer and Ebola Infection.
Ebola virus glycoprotein directly triggers T lymphocyte death despite of the lack of infection.
Ebola virus convalescent blood products: where we are now and where we may need to go.